Amoéba Announces Availability of Shareholder Letter

• Amoéba announced the availability of its letter to individual shareholders on October 19, 2026.
• The approximately €10 million capital increase will fund the biocontrol commercial launch and preparations to monetize the Willa cosmetics platform.
• Subscriptions close October 23, 2026; three preferential subscription rights entitle holders to one new share at €0.30 with one free warrant.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amoéba SA published the original content used to generate this news brief on October 19, 2026, and is solely responsible for the information contained therein.